Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Biomarkers Across Neurodegenerative Diseases, 2014
    Interpreting Disease Heterogeneity in Alzheimer’s and Parkinson’s Disease

    Study Rationale:
    The memory loss that is commonly associated with Alzheimer’s disease is thought to be caused by the accumulation of a protein called amyloid that disrupts the structure and function of...

  • Biomarkers Across Neurodegenerative Diseases, 2014
    Brain Networks as Targets of Neurodegeneration in Parkinson’s and Alzheimer’s Diseases

    Study Rationale:                   
    The study is based on two recent discoveries in neuroscience: (1) the brain is organized in large scale neuronal networks; (2) the misfolded proteins implicated in...

  • Biomarkers Across Neurodegenerative Diseases, 2014
    Cortical and Functional Distinctions in Alzheimer’s and Parkinson’s Diseases

    Study Rationale:
    Alzheimer’s disease (AD) and Parkinson’s disease (PD) are clinically distinct disorders, but their pathologies overlap considerably. Understanding how these overlaps relate to the two...

  • Research Grant, 2014
    Detection of Alpha-Synuclein Oligomers for the Diagnosis of Parkinson's Disease

    Study Rationale:                   
    Parkinson's disease (PD) is associated with the presence of protein aggregates in the form of Lewy bodies composed of the protein alpha-synuclein. One of the...

  • Rapid Response Innovation Awards, 2014
    Microvesicles: Biomarker and Vehicle for the Propagation of Pathological Forms of Alpha-synuclein

    Study Rationale:
    All living cells release extracellular vesicles composed of membrane proteins and lipids as well as components of the cell. These vesicles are important in cell-to-cell communication...

  • Rapid Response Innovation Awards, 2014
    Role of Nicotinamide N-methyltransferase in Genetic Models of Parkinson’s Disease

    Study Rationale:
    There is mounting evidence linking the metabolism of the vitamin niacin to Parkinson’s disease (PD). The enzyme nicotinamide N-methyltransferase (NNMT), a key enzyme of the niacin...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.